Maryam’s training and research are based in the field of epidemiology, with a specific focus on clinical epidemiology. She has a BSc in Biology and an MSc in Clinical Epidemiology. Maryam has completed her PhD in Epidemiology at the UNSW, where she now is a Senior Lecturer.

Isabelle Boisvert works as a research and community liaison assistant in Montreal (CRCHUM/CRISM). For several years, she struggled with addiction. She was presented an employment opportunity and hired in June 2020 and contributes her lived experience and knowledge of services for people who use drugs (PWUD) to research projects.

Matthew is the program coordinator with the Canadian Association of People Who Use Drugs. He's a board member of the International Network of Health and Hepatitis in Substance Users. Matthew was also on Canada’s 64th Canadian Delegation for CND. He is a current drug user and a formerly incarcerated person.

Matthew is the program coordinator with Canadian Association of People Who Use Drugs. He’s a board member of the International Network of Health and Hepatitis in Substance Users. Matthew was also on Canada’s 64th Canadian Delegation at CND. He is a current drug user and a formerly incarcerated person.

PB is internal medicine specialist and has worked as head of internal medicine at Arud Centre for Addiction Medicine in Zurich, Switzerland since 2003. He co-founded INHSU in 2010. Philip Bruggmann is a research fellow at the Institute of Family Medicine of the University of Zurich.

Jasna Cernosa is a resident of infectious diseases working in Clinic for Infectious Diseases and Febrile Illnesses in Ljubljana, Slovenia and PhD student in the University of Ljubljana. In her PhD thesis she focuses on microelimination of hepatitis C in groups with high-risk for infection.

Julie has extensive experience developing and implementing programs assisting those most marginalised through alcohol and other drugs and/or mental health issues. Her expertise in drug dependency treatment, counselling, therapeutic and educational group facilitation, trauma-informed care and in the provision of culturally safe and inclusive programs are central to her role.

I am a nurse since 20 years and was recently accepted as a Doctoral student at Karolinska Institutet in Stockholm. The title of my doctoral project is “Interventions for reducing mortality and morbidity among people who inject drugs – effects and experiences of a needle exchange program and naloxone distribution”.

Theofani Karaoulani is Medicine-Biopathologist in the Biopatholological Department, General Hospital of Lemnos, Lemnos, Greece. She has studied and successfully completed the course( for one year) of the Intensive Care.

Dr Lise Lafferty is a Research Fellow at UNSW Sydney with positions at Centre for Social Research in Health and The Kirby Institute. Her research interests include lived experiences of people living with chronic illnesses (with a focus on people in prison living with HCV) and addressing barriers to care.

Dr Lazarus leads the ISGlobal Health Systems Research Group, which includes viral hepatitis elimination studies. He is vice-chair of the EASL International Liver Foundation, is a core member of the Lancet Gastroenterology and Hepatology Commission on Viral Hepatitis and is a working group chair of the EASL-Lancet Liver Health Commission.

David Lessard, PhD (Anthropology), is a research assistant at the Research Institute of the McGill University Health Centre. Specialized in qualitative, participatory research, and patient and stakeholder engagement, his work focuses on patient-oriented research and innovative intervention development in the fields of infectious diseases and chronic care.

Alexandria Macmadu, MSc is a doctoral candidate in the in the Department of Epidemiology at the Brown University School of Public Health in Providence, RI, USA. Her primary research interests relate to opioid use disorder, overdose prevention, treatment access, and racial/health disparities in the criminal legal system.

The main research focus is understanding of how mental health influences drug-related risk behaviors and drug use patterns among people who inject drugs in large urban setting.

Cristina Marcos-Fosch is an Internal Medicine physician currently working in the field of viral hepatitis in Vall Hebron Hospital.

Dr. Lara Marquez is an infectious disease epidemiologist and modeler and current postdoctoral researcher at the University of California San Diego. Her research focuses on the intersection between hepatitis C transmission and prevention modeling among marginalized populations and public policy to turn data-driven strategies into actionable public health solutions.

Nanor is an PhD candidate in Public Health & Epidemiology at the Université de Montréal. Her research focuses on geographic and contextual determinants of drug use and related harms among people who inject drugs.

Outreach Coordinator at the REACH Program at Mount Sinai Hospital in New York City. MPH candidate with a concentration in epidemiology at NYU.

Elana Rosenthal is an infectious disease specialist with a clinical research focus on the intersection of infections and substance use disorder.

Dr Shayon Salehi MBChB BSc MRCP is a Medical Advisor at Gilead Sciences UK&I. He qualified in Medicine at Warwick University in 2012 and then undertook his specialist training in London and South East England. He has a particular clinical interest in viral hepatitis and reducing health inequalities.

Sam Shirley-Beavan is a Research Analyst in the Public Health and Social Policy team at Harm Reduction International.

Dr. Kinna Thakarar is an infectious disease and addiction medicine physician in Portland, Maine. She is an Assistant Professor of Medicine at Maine Medical Center/Tufts University School of Medicine and has a special interest in health services research related to the ID/ substance use disorder syndemic.

Dr. Me Me Thaw currently works at Médecins du Monde’s project township (Hopin) in Kachin State of Myanmar, as Base Manager. I have 8 years of extensive working experience in the field of public health in Kachin State especially at drug abuse harm reduction projects with various positions: Medical Coordinator (Methadone), ART Supervisor, Medical Team Leader, Deputy Program Manager.

Kirsten is a PhD Candidate at Glasgow Caledonian University and an Epidemiologist at NHS Public Health Scotland. Kirsten’s research is focussed on understanding harms, mainly BBVs, associated with injecting drug use and interventions that can be implemented to improve health and social outcomes among people who inject drugs.

Aaron Vanderhoff serves as the Community Outreach and Engagement Lead at the Viral Hepatitis Care Network in Toronto, Ontario, Canada. His previous work includes research on reducing the read time of HCV POCT and coordination of testing and linkage to care among immigrants and newcomers in New York City.

Dr. Jeffrey Weiss is an Associate Professor at the Icahn School of Medicine at Mount Sinai and DIrector of the Respectful & Equitable Access to Comprehensive Healthcare (REACH) Program at Mount Sinai Hospital.